Speaker Profile
Biography
Most recently, Adrian Bot, M.D., Ph.D. was the founding Chief Scientific Officer and Executive Vice President of Research and Development at Capstan Therapeutics, an Abbvie company developing next generation precision medicines with focus on in vivo CAR engineering. Previously, he held leadership roles at Kite Pharma and Kite, a Gilead Company, including Chief Scientific Officer and Vice President of Translational Medicine and Discovery Research, respectively. At Kite, he contributed to the development of first-in-class CAR T cell therapy products for cancer. Dr. Bot also served in various senior RD leadership positions at MannKind Corp and Alliance Pharmaceutical Corp, La Jolla, California. He obtained his M.D. in Romania in 1993, his Ph.D. in Biomedical Sciences at Mount Sinai School of Medicine in New York in 1998 and subsequently, he was a Guest Scientist at the Scripps Research Institute in La Jolla, California.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Cindy Perettie, EVP Kite Pharma
- TBA